LifeMD, Inc.
LFMD
$6.09
$0.030.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 20.34% | 5.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.34% | 5.39% | |||
| Cost of Revenue | 88.09% | -0.23% | |||
| Gross Profit | 13.32% | 6.01% | |||
| SG&A Expenses | 0.86% | 1.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 28.69% | 8.90% | |||
| Total Operating Expenses | 8.88% | 1.95% | |||
| Operating Income | 121.73% | 25.68% | |||
| Income Before Tax | 107.71% | 23.29% | |||
| Income Tax Expenses | -27.10% | -- | |||
| Earnings from Continuing Operations | 104.29% | 19.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -198.61% | 995.85% | |||
| Net Income | 97.93% | 25.37% | |||
| EBIT | 121.73% | 25.68% | |||
| EBITDA | 133.32% | 27.98% | |||
| EPS Basic | 85.14% | 24.12% | |||
| Normalized Basic EPS | 96.99% | 33.14% | |||
| EPS Diluted | 85.14% | 26.00% | |||
| Normalized Diluted EPS | 96.99% | 33.14% | |||
| Average Basic Shares Outstanding | 0.44% | 1.76% | |||
| Average Diluted Shares Outstanding | 0.44% | 1.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -47.29% | -0.34% | |||